Alavi A A, Riabykina G V, Zaruba A Iu, Kutsenko A I, Kukharchuk V V, Eliseev A O
Ter Arkh. 1993;65(4):58-60.
Seven patients with chronic renal failure and normokalemia underwent 56 hemodialysis procedures (4 procedures each) using a dialysis solution concentrate containing 2.0 mmol/l (4 procedures) and 3.0 mmol/l potassium (4 procedures). Other electrolytes in the concentrates were the same. It was found that administration of 2.0 mmol/l K concentrate in 4 patients led to ECG changes indicative of hypokalemia. The changes can be managed by slowing down the speed of K elimination from the blood. This is achieved with the solution concentrate containing K 3.0 mmol/l.
7例慢性肾衰竭且血钾正常的患者接受了56次血液透析治疗(每人4次),使用了含2.0 mmol/L(4次治疗)和3.0 mmol/L钾的透析液浓缩物。浓缩物中的其他电解质相同。结果发现,4例患者使用2.0 mmol/L钾浓缩物后出现了提示低钾血症的心电图变化。这些变化可通过减缓血液中钾的清除速度来处理。使用含3.0 mmol/L钾的溶液浓缩物可实现这一点。